The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years
1 other identifier
observational
75
1 country
1
Brief Summary
This study serves as a feasibility study for a birth cohort study to investigate the influence of the sequence and load of infections and vaccinations on the development of the immune system of children. In this study, the investigators aim to test the methods developed to capture acute respiratory and gastrointestinal infections and their consequences of children aged 1 to 3 years in Braunschweig, Germany. Furthermore, the investigators want to study the influence of the environment on the microbiome of children by comparing children of the same child care centre with children from different child care centres. The methods developed include a symptom diary which has to be filled out on a daily basis by the parents. Furthermore parents are asked to take monthly anterior nasal swabs and stool samples from the study child independent from symptoms as well as one sample if symptoms occur. The parents are provided with instructions and the first nasal swab will be demonstrated by trained study personal. The study is powered to compare nasal swabs taken by the trained staff and the parents as primary outcome. Secondary outcome is the performance of reminders sent to the study participants. The diary and the specimen will be mailed to the Helmholtz Centre for Infection Research where they will be analyzed for the nasal and gut microbiome. The nasal swabs taken at the time of an infection will be tested for respiratory viruses. After the study period of 3 months parents will be asked about the feasibility and acceptance of the symptom diary and taking the nasal swabs and stool specimens by means of questionnaires and interviews (face to face and focus groups). This will help our understanding of the feasibility and acceptance of the methods developed to capture acute respiratory and gastrointestinal infections of children and our understanding of the development and composition of the nasal and gut microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
February 28, 2014
CompletedFirst Posted
Study publicly available on registry
March 7, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2014
CompletedJanuary 12, 2016
January 1, 2016
7 months
February 28, 2014
January 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility and acceptance of taking nasal swabs and stool samples by parents of their child
Feasibility and acceptance of taking nasal swabs and stool samples by parents of their child measured by: * the comparison of quality of nasal swab taken by trained study personal and swab taken by parents (ß-actin and 16s rRNA) * the number of samples sent back * the feedback by parents (by quantitative and qualitative methods)
after 3 months
Secondary Outcomes (1)
Composition of faecal and nasal microbiome
at baseline
Study Arms (1)
Reminder group
the reminder group receives every 2 weeks a reminder to fill out the symptom diary (postcard or SMS)
Eligibility Criteria
children aged one to three years visiting a child care center in Braunschweig, Germany
You may qualify if:
- written informed consent from both parents or legal guardians
- child below the age of three visiting a CCC in Braunschweig, Germany
- parents or guardian with sufficient German language skills to complete study diaries and perform study tasks as required
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Helmholtz Centre for Infection Research
Braunschweig, Lower Saxony, 38124, Germany
Biospecimen
Parent-collected anterior-nasal swabs and stool samples
Study Officials
- PRINCIPAL INVESTIGATOR
Rafael Mikolajczyk, MD, MSc
Helmholtz Centre for Infection Research
- PRINCIPAL INVESTIGATOR
André Karch, MD, MSc
Helmholtz Centre for Infection Research
- PRINCIPAL INVESTIGATOR
Beate Zoch, MSc
Helmholtz Centre for Infection Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2014
First Posted
March 7, 2014
Study Start
November 1, 2013
Primary Completion
June 1, 2014
Study Completion
June 1, 2014
Last Updated
January 12, 2016
Record last verified: 2016-01